Effect of two dopamine receptor blockers on a serotonin-mediated behavioral syndrome in rats.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001565:Benzoates / Q000494:pharmacology; D004298:Dopamine; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007274:Injections, Intraperitoneal; D008124:Locomotion / Q000187:drug effects; D008297:Male; D009020:Morphine / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D010293:Pargyline / Q000008:administration & dosage / Q000037:antagonists & inhibitors; D010868:Pimozide / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects*; D012701:Serotonin / Q000494:pharmacology*; D013141:Spiro Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D013239:Stereotyped Behavior / Q000187:drug effects; D014364:Tryptophan / Q000008:administration & dosage / Q000037:antagonists & inhibitors
D001565:Benzoates; D011955:Receptors, Drug; D013141:Spiro Compounds; D010868:Pimozide; D012701:Serotonin; D009020:Morphine; D014364:Tryptophan; D010293:Pargyline; D004298:Dopamine